1. EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy 
Gervasio A. Lamas, MD, Robin Boineau, MD, MA, Christine Goertz, DC, PhD, Daniel B. Mark, MD, MPH, Yves Rosenberg, MD, Mario Stylianou, PhD, Theodore Rozema, MD, Richard L. Nahin, PhD, MPH, L. Terry Chappell, MD, Lauren Lindblad, MS, Eldrin F. Lewis, MD, Jeanne Drisko, MD, Kerry L. Lee, PhD 
American Heart Journal 
Volume 168, Issue 1, Pages e5 (July 2014)
DOI: /j.ahj
Copyright © 2014 The Authors Terms and Conditions

2. Figure 1
A, Kaplan-Meier curves (4 factorial groups, primary end point). B, Kaplan-Meier curves placebo/placebo versus active/active (primary end point).
American Heart Journal  , e5DOI: ( /j.ahj )
Copyright © 2014 The Authors Terms and Conditions

3. Figure 2
A, Kaplan-Meier curves (4 factorial groups, primary end point, diabetes). B, Kaplan-Meier curves placebo/placebo versus active/active (primary end point, diabetes).
American Heart Journal  , e5DOI: ( /j.ahj )
Copyright © 2014 The Authors Terms and Conditions